Zostavax
Payments companies reported to CMS as associated with Zostavax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zostavax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zostavax
These are the largest totals companies reported as associated with Zostavax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dennis Badman | Sanbornville, NH | Family Medicine | $27.88 |
| Christina Stephens | Sanbornville, NH | Family | $27.88 |
| Ann Abraham | Long Beach, CA | Nurse Practitioner | $25.00 |
| Albert Askarinam | Northridge, CA | Family Medicine | $25.00 |
| Allen Lawrence | Tarzana, CA | General Practice | $25.00 |
| Marta Bill | Northridge, CA | Physician Assistant | $25.00 |
| Sylva Garagulakian | Northridge, CA | Physician Assistant | $25.00 |
| Mary Bacon | Pembroke, NH | Family | $20.42 |
| Jennifer Mackenzie | Concord, NH | Family Medicine | $20.42 |
| Akosua Norgbey | Mckinney, TX | Family | $17.91 |
Prescribed Zostavax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.